Talphera Inc

NASDAQ:TLPHUnited States

Nov 13, 2024

Show headlines and story abstract

• Talphera Announces Third Quarter 2024 Financial Results and Provides Corporate Update, from 4:05PM ET on Wednesday Nov 13, 2024 by PR Newswire

  4:05PM ET on Wednesday Nov 13, 2024 by PR Newswire
  Companies Mentioned: TLPH

  Five sites actively screening with multiple patients having completed the study; two additional institutions expected to begin screening in the fourth quarter totaling seven active sites

  Cash and investments at September 30, 2024 of $11.1 million

• Press Release: Talphera Announces Third Quarter 2024 Financial Results and Provides Corporate Update, from 4:05PM ET on Wednesday Nov 13, 2024 by Dow Jones

  4:05PM ET on Wednesday Nov 13, 2024 by Dow Jones
  Companies Mentioned: TLPH
  
  capital resources sufficient to conduct its clinical studies. Although it is not possible to predict or identify all such risks and uncertainties, they may include, but are not limited to, those described under the caption "Risk Factors" and elsewhere in Talphera's annual, quarterly and current reports (i.e., Form 10-K, Form 10-Q and Form 8-K) as filed or furnished with the SEC and any subsequent public filings. You are cautioned not to place undue reliance on any such forward-looking statements, which speak only as of the date such statements were first made. To the degree financial information is included in this press release, it is in summary form only and must be considered in the context of the full details provided in Talphera's most recent annual, quarterly or current report as filed or furnished with the SEC. Talphera's SEC reports are available at www.talphera.com under the "Investors" tab. Except to the extent required by law, Talphera undertakes no obligation to publicly release the result of any revisions to these forward-looking statements to reflect new information, events or circumstances after the date hereof, or to reflect the occurrence of unanticipated events.
  

• Talphera Announces Third Quarter 2024 Financial Results and Provides Corporate Update, from 4:05PM ET on Wednesday Nov 13, 2024 by Dow Jones

  4:05PM ET on Wednesday Nov 13, 2024 by Dow Jones
  Companies Mentioned: TLPH
  
  capital resources sufficient to conduct its clinical studies. Although it is not possible to predict or identify all such risks and uncertainties, they may include, but are not limited to, those described under the caption "Risk Factors" and elsewhere in Talphera's annual, quarterly and current reports (i.e., Form 10-K, Form 10-Q and Form 8-K) as filed or furnished with the SEC and any subsequent public filings. You are cautioned not to place undue reliance on any such forward-looking statements, which speak only as of the date such statements were first made. To the degree financial information is included in this press release, it is in summary form only and must be considered in the context of the full details provided in Talphera's most recent annual, quarterly or current report as filed or furnished with the SEC. Talphera's SEC reports are available at www.talphera.com under the "Investors" tab. Except to the extent required by law, Talphera undertakes no obligation to publicly release the result of any revisions to these forward-looking statements to reflect new information, events or circumstances after the date hereof, or to reflect the occurrence of unanticipated events.